A drug trial for an unnamed pharmaceutical firm in France has left one person brain dead and five others critically ill.
The six patients were in good health until taking the oral medication in Rennes, north-west France, wrote the French Health Minister Marisol Touraine in a statement according to AFP.
She said on Friday that “a serious accident took place,” which has resulted in the study being halted and all volunteers taking part recalled.
According to the Guardian, Touraine also said that the patients were admitted to hospital at the beginning of this week and six people had taken part in the trial that was being developed by a European laboratory .
While the intended use for the new medicine is unknown, a source told AFP that the drug was a painkiller containing an active ingredient found in cannabis plants, cannabinoids.
The French state prosecutor has opened an inquiry and all trials on the unnamed drug in the clinic has been suspended.
More Must-Reads from TIME
- Eyewitness Accounts From the Trump Rally Shooting
- Politicians Condemn Trump Rally Shooting: ‘No Place for Political Violence in Our Democracy’
- From 2022: How the Threat of Political Violence Is Transforming America
- ‘We’re Living in a Nightmare:’ Inside the Health Crisis of a Texas Bitcoin Town
- Remembering Shannen Doherty , the Quintessential Gen X Girl
- How Often Do You Really Need to Wash Your Sheets?
- Welcome to the Noah Lyles Olympics
- Get Our Paris Olympics Newsletter in Your Inbox
Contact us at letters@time.com